Related Experiment Videos
[Therapeutic trial with corticosteroid for auditory neuropathy]
Guangqian Xing1, Zhiyong Liu, Dengyuan Wang
1Department of Otorhinolaryngology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. xgq@haoyisheng.com.cn
Zhonghua Er Bi Yan Hou Ke Za Zhi
|May 30, 2003
Summary
Corticosteroid therapy shows potential for treating auditory neuropathy, with two out of six patients experiencing significant hearing and speech discrimination improvements. Further research is warranted for this hearing disorder treatment.
Area of Science:
- Neurology
- Otolaryngology
- Pharmacology
Background:
- Auditory neuropathy is a complex hearing disorder affecting neural pathways.
- The pathophysiological mechanisms of auditory neuropathy are not fully understood, but immunological factors may be involved.
Observation:
- A study investigated corticosteroid treatment in six patients diagnosed with auditory neuropathy.
- Patients received a one-month course of prednisone, with gradual tapering for positive responders.
Findings:
- Two patients demonstrated significant hearing improvement, with speech discrimination scores rising from 48% to 95% and 72% to 100%.
- These two patients maintained improved hearing and speech abilities during extended follow-up periods.
- The remaining four patients did not show a positive response to the one-month corticosteroid trial.
Implications:
- Corticosteroids may be a viable therapeutic option for specific cases of auditory neuropathy.
- The findings suggest that immunological damage could be a contributing factor in auditory neuropathy.
- Further investigation into corticosteroid efficacy for auditory neuropathy is recommended.